Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Hemophilia Drugs
... at a CAGR of 5.4% over the analysis period 2023-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$21.3 Billion by the end ... Read More
-
Hemoglobinopathies
... of 7.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$676.4 Million by the end of the analysis period. ... Read More
-
Rare Hematology
... CAGR of 4.9% over the analysis period 2023-2030. Plasma Derived Factors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$18.2 Billion by the end of the ... Read More
-
Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2024-2032
... in 2023. Looking forward, IMARC Group expects the market to reach US$ 31.2 Billion by 2032, exhibiting a growth rate (CAGR) of 9.9% during 2024-2032. Hemophilia is an inherited medical disorder that affects the blood ... Read More
-
Bleeding Disorders Treatment
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Hemophilia A Treatment, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$12.3 Billion ... Read More
-
Bloodstream Infection Testing
... by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$12.7 Billion by ... Read More
-
Sickle Cell Disease Treatment
... reach US$8.6 Billion by 2030, growing at a CAGR of 18.7% over the analysis period 2023-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach ... Read More
-
Bleeding Disorders Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global bleeding disorders market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global bleeding ... Read More
-
Global Cell and Gene Therapy Market Size Study, by Therapy Type (Cell Therapy, Gene Therapy), by Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders, Others) and Regional Forecasts 2022-2032
... and Gene Therapy Market was valued at approximately USD 12.62 billion in 2023 and exhibiting a compound annual growth rate (CAGR) of 18.04% during the forecast period 2024-2032. Cell and gene therapy are advanced medical ... Read More
-
Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
... Forecast to 2029 The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, growing at a CAGR of 6.1% during the forecast period. ... Read More
-
APAC, MENA, and African sickle cell anemia markets research report Data By End User (Hospitals, Specialty Clinics, and Others), by Treatment (Pharmaceutics, Blood Transfusion, Bone Marrow Transplant, and Gene Therapy), by Region Forecast to 2032
... The sickle cell anemia market in APAC, MENA, and Africa is projected to grow at a noteworthy rate of 14.77% during the research year. Red blood cells are the main organ affected by sickle cell ... Read More
-
Iron Deficiency Anemia Therapy
... reach US$23.9 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Plasma Fractionation
... at a CAGR of 5.2% over the analysis period 2023-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$14.8 Billion by the end of the ... Read More
-
2024 Global Forecast for Sickle Cell Disease Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Global Anti-thrombin III Testing Market 2024-2028
... forecast period. The report on the anti-thrombin III testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Rare Hemophilia Factors Market 2024-2028
... forecast period. The report on the rare hemophilia factors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Plasma Fractionation Market Research Report Data by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030
... Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Industry Forecast to 2030 In 2023, the ... Read More
-
Drugs and Diagnostics for Hematological Disorders: Global Markets
... diseases. Based on product type, the diagnostic market for hematological disorders is divided into reagents & instruments and software. By end user, the market is segmented into hospitals, diagnostic labs, and others. On the basis ... Read More
-
Global Iron-Deficiency Anemia Therapy Market
... period of 2024 to 2031. Market Segmentation: Global Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
Intravenous (IV) Iron Drugs
... reach US$4.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2024-2032
... Maternity and Specialty Clinics, Diagnostic Centers), and Region 2024-2032 The global prenatal and newborn genetic testing market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.5 ... Read More
-
Europe Hemoglobinopathies Market Report and Forecast 2024-2032
... significant market share. It is driven by the rising prevalence of thalassemia and sickle cell anemia. The global market is expected to grow at a CAGR of 5.1% during the forecast period of 2024-2032, with ... Read More
-
2024 Global: Hemophilia Treatment Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
Research Assistance
